Det er ofte nødvendigt at øge heparindosis under hæmodialyse i forbindelse med erytropoietin- terapi som følge af det øgede erytrocyttal.
An increase in heparin dose during haemodialysis is frequently required during the course of therapy with erythropoietin as a result of the increased packed cell volume.